Position Paper on the Reporting of Norepinephrine Formulations in Critical Care from the Society of Critical Care Medicine and European Society of Intensive Care Medicine Joint Task Force

Patrick M Wieruszewski,Marc Leone,Benjamin Skov Kaas-Hansen,Siddharth Dugar,Matthieu Legrand,Cathrine A McKenzie,Brittany D Bissell Turpin,Antonio Messina,Prashant Nasa,Christa A Schorr,Jan J De Waele,Ashish K Khanna,Patrick M. Wieruszewski,Cathrine A. McKenzie,Brittany D. Bissell Turpin,Christa A. Schorr,Jan J. De Waele,Ashish K. Khanna

DOI: https://doi.org/10.1097/ccm.0000000000006176

IF: 8.8

2024-03-15

Critical Care Medicine

Abstract:Norepinephrine (also named noradrenaline), a catecholamine vasopressor, is ubiquitous in contemporary critical care practice. This agent is recommended by the Surviving Sepsis Campaign as a first-line vasopressor and most providers report using this agent for the correction of hypotension in septic shock ( 1–4 ). Although mortality rates from septic shock have improved, the global incidence is rising ( 5 ), increasing the usage of norepinephrine in ICUs across the world. The impact of norepinephrine in critical care practice was evident when septic shock in-hospital mortality rates increased during a brief 6-month period of critical shortage of norepinephrine in the United States, resulting in clinicians resorting to alternatives ( 6 ). Accurate and transparent handling and reporting of norepinephrine use at the bedside and in research is of utmost importance. We identified an important variation in the presentation of norepinephrine formulations across geographically distinct areas of the world. We present a Society of Critical Care Medicine (SCCM) and the European Society of Intensive Care Medicine (ESICM) joint task force position statement, discuss the concept of different norepinephrine-salt formulations, its implications for critical care practice and research, and provide global guidance on uniform practices related to norepinephrine formulation production and reporting.

critical care medicine